In another study 56, 14 patients with chronic hepatitis C were selected to receive either 50 mg of losartan daily and then compared to an untreated group of 9 patients for a 6 month period.
En otro estudio 56, se seleccionan 14 pacientes con hepatitis C crónica para administrarles losartán 50 mg día, frente a un grupo sin tratamiento n=9 durante 6 meses.